Based on the results of previous studies, the increased risk of cancer and the lower survival rate of patients with type A blood can be justified due to the reduced ability of the immune system of patients with type A blood to identify and attack tumor cells expressing antigens that are structurally similar to ABO antigen [36, 37]. Here, ABO is linked to cancer.